10x Genomics EPS of -$3.87

Feb. 17, 2021 4:05 PM ET10x Genomics, Inc. (TXG)TXGBy: Gaurav Batavia, SA News Editor
  • 10x Genomics (NASDAQ:TXG): Q4 EPS of -$3.87 may not be comparable to consensus of -$0.23.
  • Revenue of $112.2M (+49.0% Y/Y) beats by $11.8M.
  • 2021 Financial Guidance: 10x Genomics expects full year 2021 revenue to be in the range of $480 million to $500 million, representing 61% to 67% growth over full year 2020 revenue.

  • Press Release

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.